# US 2004/0203133 A1 · Helper dependent adenoviral vector system and methods for using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0203133 A1
- Document ID: US20040203133A1
- Status: Published application
- Kind: A1
- Application number: 10/753,962
- Filed: 2004-01-07
- Published: 2004-10-14
- Earliest claimed: 2003-01-07
- Inventors: Anja Ehrhardt; Mark A. Kay
- Web page: https://patentgrep.com/patent/US20040203133A1

## CPC

- C12N 15/86: Viral vectors
- C12N 2710/10343: viral genome or elements thereof as genetic vector
- C12N 2800/108: episomal vectors
- C12N 2800/30: Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12N 2800/90: Vectors containing a transposable element
- C12N 2830/002: inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C12N 2830/008: cell type or tissue specific enhancer/promoter combination
- C12N 2830/38: being a stuffer
- C12N 2830/42: being an intron or intervening sequence for splicing and/or stability of RNA
- C12N 2830/46: elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
- C12N 2830/85: mammalian
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A helper dependent adenoviral vector system is provided. The subject helper dependent adenoviral vector system is made up of: (1) a “gutless” adenoviral vector, which in certain embodiments includes cis-acting human stuffer DNA that provides for in vivo long term, high level expression of a coding sequence present on the vector, where in certain embodiments the vector includes an integrating domain; (2) an adenoviral helper vector that is characterized by having an adenoviral genome region flanked by recombinase recognition sites, where the helper vectors further include a non-mammalian endonuclease recognition site positioned outside of the adenoviral genome region and in certain embodiments a third adenoviral inverted terminal repeat (ITR) sequence positioned between first and second terminal ITRs; and (3) a mammalian cell that expresses the corresponding recombinase and endonuclease, as well as the adenoviral preterminal and polymerase proteins. Also provided are methods of using the subject systems to produce virions having the subject helper dependent adenoviral vectors encapsulated in an adenoviral capsid. In addition, kits for use in practicing the subject methods are provided.

## Claims

### Claim 1

A system for use in producing an adenoviral vector, said system comprising:
(a) a helper dependent adenoviral vector helper comprising:
(i) at least one restriction endonuclease site;
(ii) a stuffer region made up of a nucleic acid having one or more cis-acting sequences found in human genomic nucleic acids that provide for high level and long-term in vivo expression of a coding sequence present on said vector; and
(iii) a packaging sequence;
wherein components (i), (ii) and (iii) are flanked by adenoviral ITR sequences;
(b) an adenoviral helper vector comprising:
(i) an adenoviral vector coding sequence or portion thereof positioned in a first region between first and second recombinase recognition sites that recombine with each other and are recognized by a first recombinase;
(ii) at least one endonuclease recognition site not found in mammalian genomic sequences, wherein said endonuclease recognition site is located in a region that is other than said first region;
wherein components (i) and (ii) are flanked by an adenoviral first and an adenoviral second ITR sequence and said vector further comprises a third adenoviral ITR sequence positioned between said first and second adenoviral vector sequences; and
(c) a mammalian cell that stably expresses: (i) said first recombinase; (ii) an endonuclease that recognizes said endonuclease recognition site not found in mammalian genomic sequences; (iii) adenoviral preterminal protein; and (iv) adenoviral polymerase.

### Claim 2 (depends on 1)

The system according to claim 1, wherein said first recombinase is Cre recombinase and said first and second recombinase recognitions sites are lox sites.

### Claim 3 (depends on 1)

The system according to claim 1, wherein said endonuclease is I-Sce-I.

### Claim 4 (depends on 1)

The system according to claim 1, wherein said mammalian cell is an immortalized human cell.

### Claim 5 (depends on 1)

The system according to claim 1, wherein said helper dependent adenoviral vector comprises an expression cassette.

### Claim 6 (depends on 5)

The system according to claim 5, wherein said expression cassette is present in an integrating element comprising said expression cassette flanked by a sites recognized by a DNA insertion mediating enzyme.

### Claim 7 (depends on 6)

The system according to claim 6, wherein said DNA insertion mediating enzyme is a transposase and said integrating element is a transposon.

### Claim 8 (depends on 6)

The system according to claim 6, wherein said integrating element is flanked by third and fourth recombinase recognition sites that recombine with each other and are recognized by a second recombinase but not said first recombinase.

### Claim 9 (depends on 1)

The system according to claim 1, wherein said third ITR sequence is sufficiently different from said first and second ITR sequences such that it does not homologously recombine with said first and second ITR sequences.

### Claim 10 (depends on 1)

The system according to claim 1, wherein said third ITR sequence is capable of serving as an origin of replication in a circular cleavage product of said helper vector.

### Claim 11

A method of producing a virion, said method comprising:
(A) contacting a cell that stably expresses: a recombinase, an endonuclease that recognizes a sequence not found in mammalian cells, an adenoviral preterminal protein and an adenoviral polymerase with:
(i) a helper dependent adenoviral vector comprising:
(a) at least one restriction endonuclease site;
(b) a stuffer region; and
(c) a packaging sequence;
wherein components (a), (b) and (c) are flanked by adenoviral ITR sequences; and
(ii) an adenoviral helper vector comprising:
(a) an adenoviral vector coding sequence or portion thereof positioned in a first region between first and second recombinase recognition sites that recombine with each other and are recognized by a first recombinase; and
(b) at least one endonuclease recognition site not found in mammalian genomic sequences, wherein said endonuclease recognition site is located in a region that is other than said first region;
wherein components (a) and (b) are flanked by an adenoviral first and
an adenoviral second ITR sequence and said vector further comprises a third adenoviral ITR sequence positioned between said first and second adenoviral vector sequences;
wherein said contacting results in entry of said helper dependent adenoviral vector and said adenoviral helper vector into said cell; and
(B) maintaining said cell under conditions sufficient to produce said virion, wherein said virion comprises said helper dependent adenoviral vector encapsulated in an adenoviral capsid.

### Claim 12 (depends on 11)

The method according to claim 11, wherein said cell produces a plurality of said virions.

### Claim 13 (depends on 12)

The method according to claim 12, wherein said plurality is substantially free of virions made up of contaminating virions comprising an adenoviral capsid encapsulating said adenoviral helper vector.

### Claim 14

An adenoviral helper vector comprising:
(a) an adenoviral vector coding sequence or portion thereof positioned in a first region between first and second recombinase recognition sites that recombine with each other; and
(b) at least one endonuclease recognition site not found in mammalian genomic sequences, wherein said endonuclease recognition site is located in a region that is other than said first region;
wherein components (a) and (b) are flanked by an adenoviral first and an adenoviral second ITR sequence and said vector further comprises a third adenoviral ITR sequence positioned between said first and second adenoviral vector sequences.

### Claim 15 (depends on 14)

The adenoviral helper vector according to claim 14, wherein said first and second recombinase recognition sites are lox sites.

### Claim 16 (depends on 14)

The adenoviral helper vector according to claim 14, wherein said third ITR sequence is sufficiently different from said first and second ITR sequences such that it does not homologously recombine with said first and second ITR sequences.

### Claim 17 (depends on 14)

The adenoviral helper vector according to claim 14, wherein said third ITR sequence is capable of serving as an origin of replication in a circular cleavage product of said helper vector.

### Claim 18 (depends on 14)

The adenoviral helper vector according to claim 14, wherein said vector is linear.

### Claim 19 (depends on 18)

The adenoviral helper vector according to claim 18, wherein said vector is present in a virion that comprises an adenoviral capsid.

### Claim 20 (depends on 14)

The adenoviral helper vector according to claim 14, wherein said vector is circular.

### Claim 21

A kit for use in preparing virions made up of a helper dependent adenoviral vector encapsulated in an adenoviral capsid protein, said kit comprising:
(a) a helper dependent adenoviral vector helper comprising:
(i) at least one restriction endonuclease site;
(ii) a stuffer region made up of a nucleic acid having one or more cis-acting sequences found in human genomic nucleic acids that provide for high and long-term in vivo expression of a coding sequence present on said vector; and
(iii) a packaging sequence;
wherein components (i), (ii) and (iii) are flanked by adenoviral ITR sequences;
(b) an adenoviral helper vector comprising:
(i) an adenoviral vector coding sequence or portion thereof positioned in a first region between first and second recombinase recognition sites that recombine with each other; and
(ii) at least one endonuclease recognition site not found in mammalian genomic sequences, wherein said endonuclease recognition site is located in a region that is other than said first region;
wherein components (i) and (ii) are flanked by an adenoviral first and an adenoviral second ITR sequence and said vector further comprises a third adenoviral ITR sequence positioned between said first and second adenoviral vector sequences; and
(c) a mammalian cell that stably expresses: (i) a recombinase that recognizes said first and second recombinase recognition sites of said adenoviral helper vector; (ii) an endonuclease that recognizes said endonuclease restriction site not found in mammalian cells; (iii) adenoviral preterminal protein; and (iv) adenoviral polymerase.
